{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:18:34Z","timestamp":1794543514680,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.clinthera.2011.09.009","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T14:19:32Z","timestamp":1318861172000},"page":"1413-1432","source":"Crossref","is-referenced-by-count":238,"title":["Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review"],"prefix":"10.1016","volume":"33","author":[{"given":"Evelyn","family":"Sarnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Crofford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.09.009_bib1","author":"Elixhauser"},{"key":"10.1016\/j.clinthera.2011.09.009_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/ard.2008.100008","article-title":"Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis","volume":"68","author":"Hoes","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2011.09.009_bib3","first-page":"1","article-title":"Medication therapy in ambulatory medical care: United States, 2003\u20134","volume":"13","author":"Raofi","year":"2006","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.clinthera.2011.09.009_bib4","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O","article-title":"Damage in systemic lupus erythematosus and its association with corticosteroids","volume":"43","author":"Zonana-Nacach","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/art.23352","article-title":"Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?","volume":"59","author":"Karp","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/rheumatology\/keh594","article-title":"The cost of glucocorticoid-associated adverse events in rheumatoid arthritis","volume":"44","author":"Pisu","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinthera.2011.09.009_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1258\/1357633042602053","article-title":"Study quality and evidence of benefit in recent assessments of telemedicine","volume":"10","author":"Hailey","year":"2004","journal-title":"J Telemed Telecare"},{"key":"10.1016\/j.clinthera.2011.09.009_bib10","first-page":"461","article-title":"Corticosteroid-associated complications in elderly Crohn's disease patients","volume":"92","author":"Akerkar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib11","unstructured":"Avina-Zubieta JA, Abrahamowicz M, Choi HK, et al. Corticosteroids increase risk for acute myocardial infarction in rheumatoid arthritis. The effects of careful modeling of cumulative exposure. Poster presented at: American College of Rheumatology 2009 Annual Meeting; October 17\u201321, 2009; Philadelphia, Pa."},{"key":"10.1016\/j.clinthera.2011.09.009_bib12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1081-1206(10)61756-5","article-title":"Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales","volume":"92","author":"Bolanos","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5 Part 1","key":"10.1016\/j.clinthera.2011.09.009_bib13","first-page":"694","article-title":"Acute adverse reactions to prednisone in relation to dosage","volume":"13","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2011.09.009_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004714-200202000-00009","article-title":"Mood changes during prednisone bursts in outpatients with asthma","volume":"22","author":"Brown","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","article-title":"Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study","volume":"169","author":"Christiansen","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib16","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.269.16.2110","article-title":"Side effects of glucocorticoid treatment","volume":"269","author":"Chrousos","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.09.009_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":">Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.surneu.2006.07.018","article-title":"Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumor","volume":"67","author":"Da Silva","year":"2007","journal-title":"Surg Neurol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","article-title":"Fracture risk with intermittent high-dose oral glucocorticoid therapy","volume":"56","author":"de Vries","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.bjc.6605314","article-title":"Glucocorticoid therapy and risk of bladder cancer","volume":"101","author":"Dietrich","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinthera.2011.09.009_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.92.2.223","article-title":"Severe varicella associated with steroid use","volume":"92","author":"Dowell","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2011.09.009_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pbc.21339","article-title":"Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia","volume":"50","author":"Einaudi","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clinthera.2011.09.009_bib23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kem062","article-title":"Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome","volume":"46","author":"Fardet","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinthera.2011.09.009_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib25","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000134381","article-title":"Adverse effects of glucocorticoid therapy for inner ear disorders","volume":"70","author":"Garcia-Berrocal","year":"2008","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.clinthera.2011.09.009_bib27","article-title":"Association of methotrexate (MTX), TNF-inhibitors (TNF-1) and prednisone (PRED) with risk of infection among RA patients","volume":"66","author":"Greenberg","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2011.09.009_bib28","first-page":"1810","article-title":"Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis\u2014a randomized study","volume":"34","author":"Hafstrom","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/153.11.1089","article-title":"Steroids and risk of upper gastrointestinal complications","volume":"153","author":"Hernandez-Diaz","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib30","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2011.09.009_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6604796","article-title":"Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study","volume":"100","author":"Jensen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinthera.2011.09.009_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib33","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2169\/internalmedicine.48.2414","article-title":"Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases","volume":"48","author":"Kameda","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2125.2009.03445.x","article-title":"Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy","volume":"68","author":"Luo","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198307073090105","article-title":"Association of adrenocorticosteroid therapy and peptic-ulcer disease","volume":"309","author":"Messer","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","article-title":"Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment","volume":"21","author":"Naber","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.clinthera.2011.09.009_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1442-200X.2008.02629.x","article-title":"Frequent methylprednisone pulse therapy is a risk factor for steroid cataracts in children","volume":"50","author":"Nerome","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.clinthera.2011.09.009_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/leu.2008.373","article-title":"Dexamethasone and the risk for adrenal suppression in multiple myeloma","volume":"23","author":"Ng","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clinthera.2011.09.009_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.psyneuen.2007.12.007","article-title":"Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus","volume":"33","author":"Nishimura","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.clinthera.2011.09.009_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","article-title":"Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2011.09.009_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpedi.1996.02170290075012","article-title":"Recent corticosteroid use and the risk of complicated varicella in otherwise immunocompetent children","volume":"150","author":"Patel","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","article-title":"Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs","volume":"114","author":"Piper","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib43","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.ejca.2007.07.002","article-title":"Dexamethasone in the maintenance phase of acute lymphoblastic leukemia treatment: Is the risk of lethal infections too high?","volume":"43","author":"Poele","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinthera.2011.09.009_bib44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib45","first-page":"329","article-title":"Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures","volume":"25","author":"Reyes","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","article-title":"Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events","volume":"96","author":"Saag","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/17453670810016641","article-title":"Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral Head","volume":"79","author":"Shibatani","year":"2008","journal-title":"Acta Orthopaedica"},{"key":"10.1016\/j.clinthera.2011.09.009_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/thx.23.6.571","article-title":"Incidence of serious complications of corticosteroid therapy in respiratory disease","volume":"23","author":"Smyllie","year":"1968","journal-title":"Thorax"},{"key":"10.1016\/j.clinthera.2011.09.009_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejim.2007.08.005","volume":"19","author":"Sosa","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib50","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clinthera.2011.09.009_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1507\/endocrj.K08E-318","article-title":"Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shimoshizu rheumatic cohort between 1986 and 2006","volume":"56","author":"Sugiyama","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.clinthera.2011.09.009_bib52","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/ar2578","article-title":"Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study","volume":"10","author":"Toms","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2011.09.009_bib53","doi-asserted-by":"crossref","first-page":"c54","DOI":"10.1159\/000097598","article-title":"Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases","volume":"105","author":"Uzu","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.clinthera.2011.09.009_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.atherosclerosis.2006.05.019","article-title":"Use of oral corticosteroids and the risk of acute myocardial infarction","volume":"192","author":"Varas-Lorenzo","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2011.09.009_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-008-9124-7","article-title":"Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures","volume":"82","author":"Vestergaard","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinthera.2011.09.009_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/thorax.56.4.279","article-title":"Adverse effects of oral corticosteroids in relation to dose in patients with lung disease","volume":"56","author":"Walsh","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.clinthera.2011.09.009_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharm Therapeutics"},{"key":"10.1016\/j.clinthera.2011.09.009_bib58","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","article-title":"ACTH, adrenal steroids, and pharmacology of the adrenal cortex","author":"Schimmer","year":"2011"},{"key":"10.1016\/j.clinthera.2011.09.009_bib59","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.1780391104","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"39","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2011.09.009_bib60","first-page":"877","article-title":"Incidence and costs to Medicare of fractures among Medicare beneficiaries aged \u226565 years\u2014United States, July 1991\u2013July 1992","volume":"45","year":"1996","journal-title":"MMWR Morb Mort Weekly Rep"},{"key":"10.1016\/j.clinthera.2011.09.009_bib61","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/met.2008.0070","article-title":"Health care utilization and costs by metabolic syndrome risk factors","volume":"7","author":"Boudreau","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.clinthera.2011.09.009_bib62","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9149(98)00136-2","article-title":"Direct medical costs of coronary artery disease in the United States","volume":"81","author":"Russell","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S1049023X00004532","article-title":"Financial implications of hospital response to bioterrorism based on diagnosis-related group analysis","volume":"22","author":"Suyama","year":"2007","journal-title":"Prehosp Disaster Med"},{"key":"10.1016\/j.clinthera.2011.09.009_bib64","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2011.09.009_bib65","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.09.009_bib66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/sleep\/30.3.263","article-title":"The direct and indirect costs of untreated insomnia in adults in the United States","volume":"30","author":"Ozminkowski","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.clinthera.2011.09.009_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2006.07.017","article-title":"Cost-of-illness studies of depression: a systematic review","volume":"98","author":"Luppa","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2011.09.009_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/da.20505","article-title":"Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder","volume":"26","author":"Mauskopf","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.clinthera.2011.09.009_bib69","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2165\/00019053-200321090-00001","article-title":"Costs of bipolar disorder","volume":"21","author":"Kleinman","year":"2003","journal-title":"Pharmacoeconomics"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T05:57:59Z","timestamp":1639202279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811006175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0149291811006175"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.09.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}